or Try an Advanced Search...

    Percutaneous Coronary Intervention Stocks List

    Symbol Grade Name % Change
    LLY D Eli Lilly and Company -2.77
    NSPR F InspireMD, Inc. -0.50
    View As Page of Charts
    Related Industries: Drug Manufacturers - Major Medical Devices
    Related Stock Lists: Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Attention Deficit Hyperactivity Disorder Bacterial Infections Benign Prostatic Hyperplasia Bipolar Depression Bipolar Disorder Bypass Bypass Surgery Cardiovascular Products Cattle Cholesterol Circulatory System Cobalt Depression Depressive Disorder Diabetes

    Related ETFs - A few ETFs which own one or more of the above listed Percutaneous Coronary Intervention stocks.

    Symbol Grade Name Weight
    IHE C iShares U.S. Pharmaceutical ETF 23.02
    MEDX F Horizon Kinetics Medical ETF 14.73
    PPH C Market Vectors Pharmaceutical ETF 11.73
    IYH C iShares U.S. Healthcare ETF 11.65
    XLV C SPDR Select Sector Fund - Health Care 11.3
    View all Percutaneous Coronary Intervention ETFs...
    Compare ETFs
    Compare IHE to MEDX Compare MEDX to PPH Compare PPH to XLV

        Percutaneous Coronary Intervention Stocks Recent News

        Date Stock Title
        May 3 LLY Amazon Stock Is on a Roll. Here’s Why It’s on This Firm’s ‘Best Ideas List.’
        May 3 LLY Amgen's peek at its GLP-1 drug trial results heightens competition in obesity market
        May 3 LLY Eli Lilly Remains Expensive Here - Minimal Margin Of Safety
        May 3 LLY Analyst unveils Amgen stock price target after weight-loss drug data
        May 3 LLY Amgen (AMGN) Q1 Earnings Top, Stock Up on Obesity Drug Update
        May 3 LLY Weight-loss drug competition heats up. Is Wegovy in trouble?
        May 3 LLY Pharma Stock Roundup: LLY, NVO, PFE Q1 Results, JNJ's New Plan to Resolve Talc Claims
        May 3 LLY Amgen Knocks Novo Nordisk's Ozempic Stock Rally. Its Stock Is Flying.
        May 3 LLY US STOCKS-Wall St set to open sharply higher on soft jobs data
        May 3 LLY Amgen shares soar as executives outline obesity drug push
        May 3 LLY US STOCKS-Futures rise on Apple, Amgen boost; jobs data awaited
        May 3 LLY How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss drugs
        May 3 LLY Eli Lilly: Don't Overpay For Miracle Drugs
        May 2 LLY 1 Wall Street Analyst Thinks Eli Lilly Stock Is Going to $892. Is It a Buy?
        May 2 LLY Analysts reveal Eli Lilly stock price targets after earnings
        May 2 LLY Weight Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
        May 2 LLY Amgen Soars After CEO Gives Update on Experimental Obesity Drug
        May 2 LLY Market Chatter: Novo Nordisk, Eli Lilly's Weight-Loss Drugs Get Price Cuts in UK
        May 2 LLY Weigh Loss Competition Heats Up In Britain, Online Pharmacies Slash Prices for Wegovy and Mounjaro
        May 2 LLY Palatin gets FDA OK to test weight loss therapy with Eli Lilly’s tirzepatide
        Related Industries: Drug Manufacturers - Major Medical Devices
        Related Stock Lists: Alzheimer's Disease Amyloid Animal Health Animal Health Products Antibiotics Attention Deficit Hyperactivity Disorder Bacterial Infections Benign Prostatic Hyperplasia Bipolar Depression Bipolar Disorder Bypass Bypass Surgery Cardiovascular Products Cattle Cholesterol Circulatory System Cobalt Depression Depressive Disorder Diabetes
        Percutaneous Coronary Intervention

        Percutaneous Coronary Intervention (PCI) is a minimally invasive procedure used to treat narrowed or blocked coronary arteries. It involves inserting a catheter into a blood vessel in the arm or leg and guiding it to the narrowed or blocked coronary artery. A balloon is then inflated to widen the artery and a stent is inserted to keep it open. PCI can improve blood flow to the heart and reduce the risk of a heart attack.

        Browse All Tags